To test the efficacy of dupilumab in patients with AERD regarding the intolerance to
salicylic acid after 6 months. This will be evaluated by oral drug provocation testing with
low dose salicylic acid after 6 months of dupilumab treatment.
Hypothesis:
After 6 months of therapy, patients will tolerate aspirin dose levels as tested with
different dosages (125mg, 250mg and 500 mg).